Search filters

List of works by Francesca Bergamo

A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer

scientific article published on 4 September 2015

Activity and Safety of Cetuximab Plus Modified FOLFOXIRI Followed by Maintenance With Cetuximab or Bevacizumab for RAS and BRAF Wild-type Metastatic Colorectal Cancer: A Randomized Phase 2 Clinical Trial.

scientific article published on 15 February 2018

Advanced gastric cancer (GC) and cancer of the gastro-oesophageal junction (GEJ): focus on targeted therapies.

scientific article published on 20 January 2011

An untreatable dyspnoea: more defendants under investigation

scientific article published on 14 February 2017

Angiogenesis inhibitors and symptomatic anal ulcers in metastatic colorectal cancer patients *.

scientific article published on 15 July 2017

Anti-EGFR monoclonal antibody panitumumab for the treatment of patients with metastatic colorectal cancer: an overview of current practice and future perspectives.

scientific article

BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection.

scientific article

Chemotherapy for operable and advanced colorectal cancer.

scientific article published on 29 May 2009

Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer

scientific article published on 11 July 2012

Corneal confocal microscopy in patients with oxaliplatin-induced peripheral neuropathy

scientific article

DPYD and UGT1A1 genotyping to predict adverse events during first-line FOLFIRI or FOLFOXIRI plus bevacizumab in metastatic colorectal cancer.

scientific article published on 21 December 2017

Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients.

scientific article published on 24 August 2017

Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial

scientific article

Efficacy of FOLFOXIRI plus bevacizumab in liver-limited metastatic colorectal cancer: A pooled analysis of clinical studies by Gruppo Oncologico del Nord Ovest.

scientific article published on 13 December 2016

FOLFOXIRI in combination with panitumumab as first-line treatment in quadruple wild-type (KRAS, NRAS, HRAS, BRAF) metastatic colorectal cancer patients: a phase II trial by the Gruppo Oncologico Nord Ovest (GONO).

scientific article published on 10 May 2013

FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: a propensity score-adjusted analysis from two randomized clinical trials.

scientific article published on 9 February 2016

FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancer

scientific article published on 15 October 2013

Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients

scientific article

Hepatoid adenocarcinoma of the colon: what should we target?

scientific article published on 12 June 2011

Immunotherapy in Gastrointestinal Cancers.

scientific article published on 3 July 2017

Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer

scientific article published on 30 October 2012

Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer.

scientific article published on 5 July 2016

Long-term course of oxaliplatin-induced polyneuropathy: a prospective 2-year follow-up study

scientific article published on 01 December 2014

Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: a phase II randomised trial

scientific article

Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer.

scientific article

Neoadjuvant sirolimus for a large hepatic perivascular epithelioid cell tumor (PEComa).

scientific article published on 27 February 2014

Outcome of patients with colorectal cancer undergoing lung metastases resection: a single-institution retrospective analysis

scientific article published on 29 June 2020

Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients.

scientific article published on 05 September 2016

Pharmacokinetic analysis of metronomic capecitabine in refractory metastatic colorectal cancer patients

scientific article published on 27 February 2018

Phase II study of single-agent cetuximab in KRAS G13D mutant metastatic colorectal cancer.

scientific article

Prediction of N0 Irradiated Rectal Cancer Comparing MRI Before and After Preoperative Chemoradiotherapy.

scientific article

Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO.

scientific article published on 8 January 2018

Prognostic significance of AMPK activation in advanced stage colorectal cancer treated with chemotherapy plus bevacizumab

scientific article

Ramucirumab for the treatment of gastric cancers, colorectal adenocarcinomas, and other gastrointestinal malignancies.

scientific article published on 5 May 2016

Role of NRAS mutations as prognostic and predictive markers in metastatic colorectal cancer.

scientific article

Selecting patients for gastrectomy in metastatic esophago-gastric cancer: clinics and pathology are not enough.

scientific article published on 4 October 2017

Single-Agent Panitumumab in Frail Elderly Patients With Advanced RAS and BRAF Wild-Type Colorectal Cancer: Challenging Drug Label to Light Up New Hope

scientific article

The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients.

scientific article published on 25 January 2018

The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients

scientific article published on 15 February 2018

The role of tumor angiogenesis as a therapeutic target in colorectal cancer

scientific article published on 17 January 2018

Ultrasound assessment of oxaliplatin-induced neuropathy and correlations with neurophysiologic findings

scientific article published on 04 September 2012

Vinorelbine in BRAF V600E mutated metastatic colorectal cancer: a prospective multicentre phase II clinical study.

scientific article published on 10 August 2017

Paulina is supported by:

About Paulina

Help